KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biocryst Pharmaceuticals (BCRX) Change in Acquisitions & Divestments: 2010-2015

Historic Change in Acquisitions & Divestments for Biocryst Pharmaceuticals (BCRX) over the last 5 years, with Dec 2015 value amounting to $6.5 million.

  • Biocryst Pharmaceuticals' Change in Acquisitions & Divestments rose 30.72% to $6.5 million in Q4 2015 from the same period last year, while for Dec 2015 it was $42.4 million, marking a year-over-year increase of 24.74%. This contributed to the annual value of $320.5 million for FY2024, which is 16.78% down from last year.
  • Per Biocryst Pharmaceuticals' latest filing, its Change in Acquisitions & Divestments stood at $6.5 million for Q4 2015, which was down 40.53% from $11.0 million recorded in Q3 2015.
  • Biocryst Pharmaceuticals' 5-year Change in Acquisitions & Divestments high stood at $24.6 million for Q3 2011, and its period low was $2.4 million during Q1 2013.
  • For the 3-year period, Biocryst Pharmaceuticals' Change in Acquisitions & Divestments averaged around $8.1 million, with its median value being $6.8 million (2013).
  • In the last 5 years, Biocryst Pharmaceuticals' Change in Acquisitions & Divestments plummeted by 84.75% in 2013 and then soared by 250.84% in 2014.
  • Over the past 5 years, Biocryst Pharmaceuticals' Change in Acquisitions & Divestments (Quarterly) stood at $6.0 million in 2011, then declined by 11.97% to $5.3 million in 2012, then increased by 21.94% to $6.5 million in 2013, then fell by 22.90% to $5.0 million in 2014, then soared by 30.72% to $6.5 million in 2015.
  • Its last three reported values are $6.5 million in Q4 2015, $11.0 million for Q3 2015, and $22.4 million during Q2 2015.